Why consider treatment in China for Nasopharyngeal Cancer?

China has the world's most extensive experience with NPC due to its high prevalence, leading to advanced expertise in intensity-modulated radiotherapy (IMRT) and combined chemo protocols. Treatment costs are significantly lower than in Western countries, often 30-50% less, while using the same or newer technology. Major cancer centers in Guangzhou, Beijing, and Shanghai have internationally trained specialists who treat hundreds of NPC cases annually, ensuring high-quality, evidence-based care.